ACTIVE

PHARMACIE PIERROT

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result18,4 k €+191,6 %over 1 year

Gross margin384 k €+12,6 %over 1 year

Equity441,1 k €-7,0 %over 1 year

Workforce3,6 ETP+20,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE PIERROT is a Private limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Mons. It employs on average 3,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0864.935.142
Incorporation: 26/04/2004
Legal form: Private limited company
Registered office: Place de Maisières 4
7020 Mons · WallonieSee on map
Contributed capital: 18 660,00 €
Latest accounts: 31/12/2025
Average workforce: 3,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores+3

Joint committees (1)

3130

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	384 k €	+12.6%	340,9 k €	-5.8%	361,8 k €	+7.8%	335,5 k €	-4.5%	351,5 k €
EBITDA	133,7 k €	+13.1%	118,2 k €	-8.4%	129,1 k €	+15.6%	111,6 k €	-34.9%	171,6 k €
Operating result	43,5 k €	+61.8%	26,9 k €	+10.1%	24,4 k €	-27.7%	33,7 k €	-69.8%	111,6 k €
Net result	18,4 k €	+192%	6,3 k €	-48.8%	12,3 k €	-49.3%	24,3 k €	-63.3%	66,1 k €
Balance sheet
Equity	441,1 k €	-7.0%	474,5 k €	-7.0%	510,2 k €	-4.3%	532,9 k €	+0.8%	528,6 k €
Total assets	956,9 k €	-2.2%	978,7 k €	-5.7%	1 M €	-12.5%	1,2 M €	+50.8%	787,1 k €
Cash	171,8 k €	+33.9%	128,3 k €	+39.6%	91,9 k €	-53.6%	198,2 k €	+22.2%	162,2 k €
Debts	515,2 k €	+2.3%	503,6 k €	-4.5%	527,5 k €	-19.3%	653,3 k €	+153%	258,5 k €
Other
Workforce	3,6 ETP	+20.0%	3,0 ETP	-21.1%	3,8 ETP	+8.6%	3,5 ETP	+6.1%	3,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

Cécile Ducarreaux

Director

Active

Ended mandates

Françoise GERODEZ

Director · since 17 février 2012

Ended

ALPHAR PARTNERS

Director · since 01 janvier 2005 · until 21 avril 2009 · 0475.639.696

Represented by Peter Van Elslander

Ended

Cécile DUCARREAUX

Managing director · since 01 janvier 2005 · until 21 avril 2009

Ended

ALPHAR PARTNERS

Director · 0475.639.696

Represented by Peter Van Elslander

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/04/2026	17/07/2025	18/07/2024	14/06/2023	13/07/2022	20/08/2021
General meeting	12/04/2026	17/07/2025	18/07/2024	13/06/2023	26/04/2022	27/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	12/04/2026	14/04/2026	French	PDF
Abridged model	31/12/2024	17/07/2025	17/07/2025	French	PDF
Abridged model	31/12/2023	18/07/2024	18/07/2024	French	PDF
Abridged model	31/12/2022	13/06/2023	14/06/2023	French	PDF
Abridged model	31/12/2021	26/04/2022	13/07/2022	French	PDF
Abridged model	31/12/2020	27/04/2021	20/08/2021	French	PDF
Abridged model	31/12/2019	25/03/2020	31/03/2020	French	PDF
Abridged model	31/12/2018	30/06/2019	17/07/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	29/08/2018	French	PDF
Abridged model	31/12/2016	09/03/2017	04/04/2017	French	PDF
Abridged model	31/12/2015	15/04/2016	27/04/2016	French	PDF
Abridged model	31/12/2014	15/05/2015	22/05/2015	French	PDF
Abridged model	31/12/2013	30/06/2014	11/07/2014	French	PDF
Full model	31/12/2012	12/03/2013	22/04/2013	French	PDF
Full model	31/12/2011	20/04/2012	04/05/2012	French	PDF
Full model	31/12/2010	30/06/2011	19/07/2011	French	PDF
Full model	31/12/2009	19/03/2010	03/05/2010	French	PDF
Full model	31/12/2008	29/05/2009	02/07/2009	French	PDF
Full model	31/12/2007	23/06/2008	08/07/2008	French	PDF
Full model	31/12/2006	15/03/2007	29/03/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

Cécile Ducarreaux

Director

Active

Ended mandates

Françoise GERODEZ

Director · since 17 février 2012

Ended

ALPHAR PARTNERS

Director · since 01 janvier 2005 · until 21 avril 2009 · 0475.639.696

Represented by Peter Van Elslander

Ended

Cécile DUCARREAUX

Managing director · since 01 janvier 2005 · until 21 avril 2009

Ended

ALPHAR PARTNERS

Director · 0475.639.696

Represented by Peter Van Elslander

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Mandates26/04/2013
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Capital / shares10/01/2013
CAPITAL, ACTIONS
PDF
Restructuring04/01/2013
DENOMINATION - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring13/07/2012
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates07/03/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates06/12/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates03/02/2010
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202518,4 k €↑
2024
Annual accounts 20246,3 k €↓
2023
Annual accounts 202312,3 k €↓
2022
Annual accounts 202224,3 k €↓
2021
Annual accounts 202166,1 k €↑
2020
Annual accounts 202041,8 k €↑
2019
Annual accounts 201933,1 k €↓
2018
Annual accounts 201837,8 k €↑
2017
Annual accounts 201721,4 k €↓
2016
Annual accounts 201654,7 k €↑
2015
Annual accounts 201514,5 k €↓
2014
Annual accounts 201429,5 k €↑
2013
Annual accounts 20135,7 k €↓
2012
Annual accounts 201227 k €↓
2011
Annual accounts 201137,2 k €↑
2010
Annual accounts 201034,9 k €↑
2009
Annual accounts 200933,6 k €↑
2008
Annual accounts 200831,7 k €↑
2007
Annual accounts 200726,1 k €
26/04/2004
IncorporationPrivate limited company

PHARMACIE PIERROT

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline